Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
I will accept. The stock rose from 2.2x till today is due to previous speculation of acquisition (first appeared in the edge 19july). If acquisition fails, the price will drop and will take long to recover. Malaysia pharmaceuticals only do generic medicines and this space is very competitive. Another segment of company is distribution, this has lower margin and market is being absorbed by zuellig and dksh. Simply put, there isnt any catalyst for *big* increase in profit in near to medium term (small increase is certain). Company cough syrup is the only non-replaceable so far in the market.
Unlike genm, the consortium led by Quadria has secured about 73% of shares, so i think they are not eager to sapu from market. Genm has only crossed 50% last week (the % to enable the offer to become unconditional)
It takes maybe up to 6 months or more to finalize everything. So there is time cost. Second, some ppl bought using margin, and the margin interest > 4% difference between 2.54 to 2.64
Samantha: another reason ppl sell now is probably due to they dont want to wait for the whole process which could take many months. So they are ok to lose 2-3 % than holding the stock for another, say 6 months.
Some still think that the offer will fail. They wont get the rm2.64. And the founder himself is selling to others, that is not a good sign. (Info: even if this deal succeed, Dr Kee will only hold 6% of the final + cash)
Augustine: can read the latest news: Apex healthcase offer may turn unconditional. The author has excluded WHSP (29%). WHSP has agreed (in writing) to sell
